Your browser doesn't support javascript.
loading
Population analyses of mosaic X chromosome loss identify genetic drivers and widespread signatures of cellular selection.
Liu, Aoxing; Genovese, Giulio; Zhao, Yajie; Pirinen, Matti; Zekavat, Maryam M; Kentistou, Katherine; Yang, Zhiyu; Yu, Kai; Vlasschaert, Caitlyn; Liu, Xiaoxi; Brown, Derek W; Hudjashov, Georgi; Gorman, Bryan; Dennis, Joe; Zhou, Weiyin; Momozawa, Yukihide; Pyarajan, Saiju; Tuzov, Vlad; Pajuste, Fanny-Dhelia; Aavikko, Mervi; Sipilä, Timo P; Ghazal, Awaisa; Huang, Wen-Yi; Freedman, Neal; Song, Lei; Gardner, Eugene J; Sankaran, Vijay G; Palotie, Aarno; Ollila, Hanna M; Tukiainen, Taru; Chanock, Stephen J; Mägi, Reedik; Natarajan, Pradeep; Daly, Mark J; Bick, Alexander; McCarroll, Steven A; Terao, Chikashi; Loh, Po-Ru; Ganna, Andrea; Perry, John R B; Machiela, Mitchell J.
Afiliação
  • Liu A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Genovese G; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Zhao Y; These authors contributed equally: Aoxing Liu, Giulio Genovese, Yajie Zhao.
  • Pirinen M; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Zekavat MM; Stanley Center, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Kentistou K; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Yang Z; These authors contributed equally: Aoxing Liu, Giulio Genovese, Yajie Zhao.
  • Yu K; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Vlasschaert C; These authors contributed equally: Aoxing Liu, Giulio Genovese, Yajie Zhao.
  • Liu X; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Brown DW; Department of Publich Health, University of Helsinki, Helsinki, Finland.
  • Hudjashov G; Department of Mathematics and Statistics, University of Helsinki, Helsinki, Finland.
  • Gorman B; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Dennis J; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.
  • Zhou W; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Momozawa Y; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Pyarajan S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Tuzov V; Department of Medicine, Queen's University, Kingston, ON, Canada.
  • Pajuste FD; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Aavikko M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Sipilä TP; Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.
  • Ghazal A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Huang WY; Center for Data and Computational Sciences (C-DACS), VA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA, USA.
  • Freedman N; Booz Allen Hamilton, McLean, VA, USA.
  • Song L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Gardner EJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Sankaran VG; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Palotie A; Center for Data and Computational Sciences (C-DACS), VA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA, USA.
  • Ollila HM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Tukiainen T; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Chanock SJ; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Mägi R; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Natarajan P; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Daly MJ; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Bick A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • McCarroll SA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Terao C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Loh PR; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Ganna A; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Perry JRB; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Machiela MJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
medRxiv ; 2023 Jan 31.
Article em En | MEDLINE | ID: mdl-36778285
ABSTRACT
Mosaic loss of the X chromosome (mLOX) is the most commonly occurring clonal somatic alteration detected in the leukocytes of women, yet little is known about its genetic determinants or phenotypic consequences. To address this, we estimated mLOX in >900,000 women across eight biobanks, identifying 10% of women with detectable X loss in approximately 2% of their leukocytes. Out of 1,253 diseases examined, women with mLOX had an elevated risk of myeloid and lymphoid leukemias and pneumonia. Genetic analyses identified 49 common variants influencing mLOX, implicating genes with established roles in chromosomal missegregation, cancer predisposition, and autoimmune diseases. Complementary exome-sequence analyses identified rare missense variants in FBXO10 which confer a two-fold increased risk of mLOX. A small fraction of these associations were shared with mosaic Y chromosome loss in men, suggesting different biological processes drive the formation and clonal expansion of sex chromosome missegregation events. Allelic shift analyses identified alleles on the X chromosome which are preferentially retained, demonstrating that variation at many loci across the X chromosome is under cellular selection. A novel polygenic score including 44 independent X chromosome allelic shift loci correctly inferred the retained X chromosomes in 80.7% of mLOX cases in the top decile. Collectively our results support a model where germline variants predispose women to acquiring mLOX, with the allelic content of the X chromosome possibly shaping the magnitude of subsequent clonal expansion.

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia